Emergent Biosolutions Inc
EBS
Market Cap$442.81M
Close$
$0.90
88.1% downside
Current Fair Value
88.1% downsideOvervalued by 88.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $442.81 Million |
|---|---|
| Enterprise Value | $811.81 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-3.6 |
| Beta | 1.98 |
| Outstanding Shares | 54,200,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 3.22 |
|---|---|
| PEG | -1.38 |
| Price to Sales | 0.51 |
| Price to Book Ratio | 0.84 |
| Enterprise Value to Revenue | 0.99 |
| Enterprise Value to EBIT | 5.05 |
| Enterprise Value to Net Income | 5 |
| Total Debt to Enterprise | 0.78 |
| Debt to Equity | 1.19 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Emergent Biosolutions Inc
CEO: Robert Kramer